表紙
市場調查報告書

實驗動物模型,3D培養及類器官的全球市場

Laboratory Animal Models, 3D Cultures and Organoids

出版商 BCC Research 商品編碼 807093
出版日期 內容資訊 英文 198 Pages
訂單完成後即時交付
價格
實驗動物模型,3D培養及類器官的全球市場 Laboratory Animal Models, 3D Cultures and Organoids
出版日期: 2019年03月08日內容資訊: 英文 198 Pages
簡介

全球實驗動物模型的市場規模,預計從2018年的59億美元到2023年擴大到78億美元,其間為5.6%的年複合成長率。

本報告提供全球實驗動物模型,3D培養及類器官市場相關調查分析,市場概要,技術的背景,市場趨勢分析與預測,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 摘要、亮點

第3章 動物模型市場技術背景

  • 動物模型及3D細胞培養修正的方法
  • 實驗動物模型

第4章 3D細胞培養市場分析:各技術

  • 3D細胞培養
  • 再生醫療、生物印刷
  • 微流體生物功能晶片 (Organ-on-Chip) 平台

第5章 類器官市場分析:各技術

  • 類器官

第6章 市場分析:各終端用戶

  • 動物模型:各終端用戶
  • 3D細胞培養:各終端用戶

第7章 市場分析:各用途

  • 藥物研發,癌症研究及個體化醫療
  • 毒性、安全性檢驗

第8章 市場分析:各地區

  • 亞太地區
  • 北美
  • 歐洲
  • 中東、非洲 (MEA)
  • 南美

第9章 專利檢討/新開發

第10章 市場機會分析

  • 市場機會:動物模型
  • 市場機會:3D細胞培養市場區隔
  • 3D細胞培養、動物模型的優點及缺點

第11章 企業、重要機關的簡介

  • 動物模型企業
    • ALPHAGENESIS INC.
    • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
    • COVANCE INC.
    • CROWN BIOSCIENCE INC.
    • ENVIGO
    • GENOWAY S.A.
    • JACKSON LABORATORY
    • JANVIER LABS
    • OAK HILL GENETICS
    • PRIMGEN
    • TACONIC BIOSCIENCES
    • TRANSGENIC INC.
    • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • 生物印刷、再生醫療企業
    • ALLEVI
    • ASPECT BIOSYSTEMS LTD.
    • BIOINK SOLUTIONS INC.
    • CELLINK INC.
    • COLLPLANT HOLDINGS LTD.
    • EAST RIVER BIOSOLUTIONS/XYLYX BIO
    • EPIBONE
    • MATTEK CORP.
    • NANO 3D BIOSCIENCES INC.
    • ORGANOVO HOLDINGS INC.
    • PEPGEL LLC
    • REGENHU
    • TEVIDO BIODEVICES INC.
    • TISSUSE GMBH
  • 生物功能晶片 (Organ-on-Chip) 企業
    • AXOSIM
    • EMULATE, INC.
    • KIRKSTALL LTD.
    • MICRONIT MICROTECHNOLOGIES
    • MIMETAS
    • TARA BIOSYSTEMS INC.
  • 類器官企業
    • 3DNAMICS
    • CELLESCE
    • CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
    • HUBRECHT ORGANOID TECHNOLOGY
    • QGEL
    • R&D SYSTEMS INC.
    • STEMCELL TECHNOLOGIES INC.
    • TREVIGEN INC.
  • 其他3D細胞培養企業
    • 3D BIOTEK LLC
    • ADVANCED BIOMATRIX INC.
    • HORIZON DISCOVERY GROUP PLC
    • IN SPHERO INC.
    • MERCK & CO., INC.
    • PROMOCELL GMBH
    • REPROCELL INC.
    • SYNTHECON, INC.
目錄
Product Code: PHM204A

Report Highlights:

The global market for laboratory animal models should grow from $5.9 billion in 2018 to $7.8 billion by 2023, increasing at a compound annual growth rate (CAGR) of 5.6% for the period of 2018-2023.

The global market for laboratory mice as an animal model should grow from $2.7 billion in 2018 to over $3.4 billion by 2023, increasing at a CAGR of 5.0% for the period of 2018-2023.

The global market for nonhuman primates as an animal model should grow from $1.7 billion in 2018 to $2.7 billion by 2023, increasing at a CAGR of 8.9% for the period of 2018-2023.

Report Scope:

The report describes three global markets: the animal model market, the 3D cultures market and the organoid market. The organoid market is described in more detail in a separate chapter of the report.

Report Includes:

  • 49 data tables 16 additional tables
  • Comprehensive overview of the global markets for laboratory animal models, 3D cell cultures and organoids
  • Analyses of global market trends, with data from 2016, 2017 and 2018; estimates for 2019 to 2022; and projections of compound annual growth rates (CAGRs) through 2023
  • Country specific data and analysis for Australia, China, Japan, U.S., Canada, Mexico, Brazil, U.K., France, Germany, Israel and Middle East
  • Information on current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
  • Discussion of most significant trends in the 3D cell culture industry, including the bioprinting, organ-on-chip and organoid segments
  • Review of selected patents and patent applications on laboratory animal models for a brief period of 2006 to 2018
  • Company profiles of major market players within the industry, including Charles River Laboratories, Envigo, Crown Bioscience Inc., Genoway S.A., Taconic Biosciences and Merck & Co., Inc.

Table of Contents

Chapter 1: Introduction

  • Background
  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources and Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Laboratory Animal Models
  • 3D Cell Cultures

Chapter 3: Animal Model Market Technology Background

  • Methods of Animal Model and 3D Cell Culture Modification
    • Physical and Chemical Mutations
    • Targeted Mutations
  • Laboratory Animal Models
    • Market Definition
    • Animal Model Lines
    • Common Species of Laboratory Animals
    • Current Trends in Animal Model Usage

Chapter 4: 3D Cell Cultures Market Breakdown by Technology

  • 3D Cell Cultures
    • Spheroids
    • 3D Cultures vs. 2D Cultures vs. 2.5D Cultures
    • Scaffold-Based and Scaffold-Free 3D Cell Cultures
    • Scaffold-Free 3D Cell Cultures
    • Scaffold-Based 3D Cell Cultures
  • Tissue Engineering and Bioprinting
    • 3D Bioprinting Technology
  • Microfluidic Organ-on-Chip Platforms
    • Types of Organ-on-Chip Devices

Chapter 5: Organoids Market Breakdown by Technology

  • Organoids
    • Introduction
    • Organoids Technology and Principles
    • Organoid Technology Timeline
    • Types of Organoids
    • Organoid Biobanking and Libraries
    • Organoid System Complexity

Chapter 6: Market Breakdown by End User

  • Animal Models by End User
    • Academia and Research Institutions
    • Biomedical and Pharmaceutical Companies
    • Regulatory Processes and Routine Production
    • Cosmetics Industry
  • 3D Cell Cultures by End User
    • Basic Research
    • Biomedical and Pharma Companies
    • Regulatory Processes and Routine Production
    • Cosmetics Industry

Chapter 7: Market Breakdown by Application

  • Drug Discovery, Cancer Research and Personalized Medicine
    • Drug Discovery and High-throughput Compound Screening
    • Cancer Research
    • Personalized Medicine
    • Regenerative Medicine and Transplantations
  • Toxicity and Safety Testing
    • Drug Toxicity Testing

Chapter 8: Market Breakdown by Region

  • Asia-Pacific (APAC)
    • Australia
    • China
    • Japan
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Great Britain
    • Germany
    • France
    • Rest of Europe
  • Middle East and Africa (MEA)
    • Israel
  • South America
    • Brazil

Chapter 9: Patent Review/New Developments

Chapter 10: Analysis of Market Opportunities

  • Market Opportunities: Animal Models
  • Market Opportunities: 3D Cell Culture Segment
    • Organs-on-Chip
    • Organoids
    • Bioprinting
  • Advantages and Disadvantages of 3D Cell Cultures and Animal Models
    • Animal Models
    • 3D Cell Cultures in General
    • Organoids
    • Organs-on-Chip

Chapter 11: Profiles of Companies and Important Institutions

  • Animal Model Companies
    • ALPHAGENESIS INC.
    • CHARLES RIVER LABORATORIES INTERNATIONAL INC.
    • COVANCE INC.
    • CROWN BIOSCIENCE INC.
    • ENVIGO
    • GENOWAY S.A.
    • JACKSON LABORATORY
    • JANVIER LABS
    • OAK HILL GENETICS
    • PRIMGEN
    • TACONIC BIOSCIENCES
    • TRANSGENIC INC.
    • TRANSPOSAGEN BIOPHARMACEUTICALS INC.
  • Bioprinting and Regenerative Medicine Companies
    • ALLEVI
    • ASPECT BIOSYSTEMS LTD.
    • BIOINK SOLUTIONS INC.
    • CELLINK INC.
    • COLLPLANT HOLDINGS LTD.
    • EAST RIVER BIOSOLUTIONS/XYLYX BIO
    • EPIBONE
    • MATTEK CORP.
    • NANO 3D BIOSCIENCES INC.
    • ORGANOVO HOLDINGS INC.
    • PEPGEL LLC
    • REGENHU
    • TEVIDO BIODEVICES INC.
    • TISSUSE GMBH
  • Organ-on-Chip Companies
    • AXOSIM
    • EMULATE, INC.
    • KIRKSTALL LTD.
    • MICRONIT MICROTECHNOLOGIES
    • MIMETAS
    • TARA BIOSYSTEMS INC.
  • Organoid Companies
    • 3DNAMICS
    • CELLESCE
    • CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
    • HUBRECHT ORGANOID TECHNOLOGY
    • QGEL
    • R&D SYSTEMS INC.
    • STEMCELL TECHNOLOGIES INC.
    • TREVIGEN INC.
  • Other 3D Cell Culture Companies
    • 3D BIOTEK LLC
    • ADVANCED BIOMATRIX INC.
    • HORIZON DISCOVERY GROUP PLC
    • IN SPHERO INC.
    • MERCK & CO., INC.
    • PROMOCELL GMBH
    • REPROCELL INC.
    • SYNTHECON, INC.

List of Tables

  • Summary Table A: Global Market for Laboratory Animal Models, by Type, Through 2023
  • Summary Table B: Global Market for Organs-on-Chips and Organoids, Through 2023
    • Table 1: Global Market for Laboratory Mice, by Region, Through 2023
    • Table 2: Global Market for Laboratory Rats, by Region, Through 2023
    • Table 3: Global Market for Laboratory Guinea Pigs, by Region, Through 2023
    • Table 4: Global Market for Laboratory Rabbits, by Region, Through 2023
    • Table 5: Global Market for Laboratory Hamsters, by Region, Through 2023
    • Table 6: Global Market for Laboratory Cats, by Region, Through 2023
    • Table 7: Global Market for Laboratory Dogs, by Region, Through 2023
    • Table 8: Global Market for Laboratory Pigs, by Region, Through 2023
    • Table 9: Global Market for Laboratory Nonhuman Primates, by Region, Through 2023
    • Table 10: Tissue Engineering Related Search Terms in PubMed, Through 2018
    • Table 11: Tissue Bioprinting Related Search Terms in PubMed, Through 2018
    • Table 12: Organ-on-Chip Related Search Terms in PubMed, Through 2018
    • Table 13: Investments in Organ-on-Chip Technology, by Company, Through 2018
    • Table 14: Global Market for Organs-on-Chips, Through 2023
    • Table 15: Organoid Types Mentioned in PubMed Articles, Through 2018
    • Table 16: Mentions of Spheroids in PubMed Articles, Through 2018
    • Table 17: Organoid Centers
    • Table 18: Global Market for Organoids, by Type, Through 2023
    • Table 19: Global Market for Animal Models, by End User, Through 2023
    • Table 20: Continents Banning Animal Testing for Cosmetics, by Country and Year Banned, 2013-2019
    • Table 21: Asia-Pacific Market for Laboratory Animal Models, by Type, Through 2023
    • Table 22: Australian Market for Laboratory Animal Models, by Type, Through 2023
    • Table 23: Chinese Market for Laboratory Animal Models, by Type, Through 2023
    • Table 24: Japanese Market for Laboratory Animal Models, by Type, Through 2023
    • Table 25: North American Market for Laboratory Animal Models, by Type, Through 2023
    • Table 26: U.S. Market for Laboratory Animal Models, by Type, Through 2023
    • Table 27: Canadian Market for Laboratory Animal Models, by Type, Through 2023
    • Table 28: Mexican Market for Laboratory Animal Models, by Type, Through 2023
    • Table 29: European Market for Laboratory Animal Models, by Type, Through 2023
    • Table 30: Great Britain Market for Laboratory Animal Models, by Type, Through 2023
    • Table 31: German Market for Laboratory Animal Models, by Type, Through 2023
    • Table 32: French Market for Laboratory Animal Models, by Type, Through 2023
    • Table 33: Rest of European Market for Laboratory Animal Models, by Type, Through 2023
    • Table 34: Middle Eastern and African Market for Laboratory Animal Models, by Type, Through 2023
    • Table 35: Israeli Market for Laboratory Animal Models, by Type, Through 2023
    • Table 36: South American Market for Laboratory Animal Models, by Type, Through 2023
    • Table 37: Brazilian Market for Laboratory Animal Models, by Type, Through 2023
    • Table 38: Review of Selected Patents and Patent Applications on Laboratory Animal Models, 2006-2018
    • Table 39: Global Number of Transplanted Organs, by Country, 2017
    • Table 40: Charles River Laboratories: Segments
    • Table 41: Charles River Laboratories: Revenue, 2013-2017
    • Table 42: Charles River Laboratories: RMS Company Yearly Revenues/Operating Income, by Quarter, 2016 and 2017
    • Table 43: Charles River Laboratories: Company Business Structure Data, by Segment, 2017
    • Table 44: Crown Bioscience Inc.: Segments
    • Table 45: Envigo: Segments
    • Table 46: Envigo: Consolidated Revenue, by Segment, 2015-2018
    • Table 47: Envigo: RMS Quarterly Revenue, 2015-2018
    • Table 48: Envigo: Types of Laboratory Animals
    • Table 49: Genoway S.A.: Segments
    • Table 50: Genoway S.A.: Sales, 2016 and 2017
    • Table 51: Jackson Laboratory: Segments
    • Table 52: Jackson Laboratory: Company Data, 2013-2016
    • Table 53: Janvier Labs: Segments
    • Table 54: Taconic Biosciences: Segments
    • Table 55: Transgenic Inc.: Segments
    • Table 56: Transgenic Inc.: Company Data, 2014-2018
    • Table 57: Transposagen Biopharmaceuticals Inc.: Segments
    • Table 58: Organovo: Expenses on R&D, 2013-2018
    • Table 59: 3D Biotek LLC: Segments
    • Table 60: In Sphero Inc.: Segments
    • Table 61: Merck & Co., Inc.: Revenue, by Region
    • Table 62: Merck & Co., Inc.: Company Data, 2013-2017
    • Table 63: Reprocell Inc.: Acquisitions

List of Figures

  • Summary Figure A: Global Market for Laboratory Animal Models, by Type, 2016-2023
  • Summary Figure B: Global Market for Organ-on-Chip and Organoids, 2017-2023
    • Figure 1: PubMed Timeline for the Mesh Terms of Types of Mice, 2000-2017
    • Figure 2: Global Market for Laboratory Mice, by Region, 2016-2023
    • Figure 3: PubMed Timeline for the Mesh Terms of Types of Rats, 2000-2017
    • Figure 4: Global Market for Laboratory Rats, by Region, 2016-2023
    • Figure 5: Global Market for Laboratory Guinea Pigs, by Region, 2016-2023
    • Figure 6: Global Market for Laboratory Rabbits, by Region, 2016-2023
    • Figure 7: Global Market for Laboratory Hamster, by Region, 2016-2023
    • Figure 8: Global Market for Laboratory Cats, by Region, 2016-2023
    • Figure 9: Global Market for Laboratory Dogs, by Region, 2016-2023
    • Figure 10: Global Market for Laboratory Pigs, by Region, 2016-2023
    • Figure 11: Global Market for Laboratory Nonhuman Primates, by Region, 2016-2023
    • Figure 12: Tissue Engineering Related Search Terms in PubMed, 2010-2018
    • Figure 13: Tissue Bioprinting Related Search Terms in PubMed, 2010-2018
    • Figure 14: Timeline for Possible Availability of 3D Printed Organs and Tissues for Humans, 2018-2043
    • Figure 15: Organ-on-Chip Related Search Terms in PubMed, 2010-2018
    • Figure 16: Investments in Organ-on-Chip Technology, by Company, 2008-2018
    • Figure 17: Global Market for Organs-on-Chips, 2017-2023
    • Figure 18: Timeline for Possible Availability of Organ-on-Chip Devices for Drug Screening in Human Patients, 2018-2030
    • Figure 19: Organoid Types Mentioned in PubMed Articles, 2010-2018
    • Figure 20: Mentions of Spheroids in PubMed Articles, 2010-2018
    • Figure 21: Global Market for Organoids, by Type, 2017-2023
    • Figure 22: Global Market for Animal Models, by End User, 2016-2023
    • Figure 23: Asia-Pacific Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 24: Australian Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 25: Chinese Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 26: Japanese Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 27: North American Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 28: U.S. Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 29: U.S. National Toxicology Program Funding for Toxicity Testing, 2013-2018
    • Figure 30: Canadian Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 31: Mexican Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 32: European Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 33: Great Britain Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 34: German Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 35: French Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 36: Rest of European Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 37: Middle Eastern and African Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 38: Israeli Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 39: South American Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 40: Brazilian Market for Laboratory Animal Models, by Type, 2016-2023
    • Figure 41: Global Number of Transplanted Organs, by Country, 2017
    • Figure 42: Charles River Laboratories: Number of Employees
    • Figure 43: Charles River Laboratories: RMS Company Yearly Revenues/Operating Income, by Quarter, 2016 and 2017
    • Figure 44: Charles River Laboratories: Revenue Share, by Segment, 2017
    • Figure 45: Envigo: Consolidated Revenue, by Segment, 2015-2018
    • Figure 46: Envigo: RMS Quarterly Revenue, 2015-2018
    • Figure 47: Merck & Co., Inc.: Revenue, by Region